Learner Assessment: Enduring Activity
"Are GLP-1s a double-edged syringe? Disordered eating guidance for dietitians in any setting"

The CPEUs for the enduring activity expires May 15, 2029. Please access your certificate before then.

Privacy Collection Statement

The purpose of this statement is to advise you that we may collect, use and disclose various personal information about you, for the purposes of providing services to you, facilitating our internal business operations, including the fullfilment of any legal and regulatory requirements and providing you with information about us and the services that we offer. More detailed information about the way we use, disclose and secure your personal information, and how you can access that information, can be found in our privacy policy, available on the Dietitian Connection website or by contacting us using our details shown on the website.

Thank you for watching the webinar. This learner assessment follows the latest requirements from the Commission on Dietetic Registration to assess the extent of learners’ understanding/comprehension of the educational content.

Question Title

* 1. Please enter your name

Question Title

* 2. Please enter your email address

Question Title

* 3. What does a SCOFF score of 2 or more suggests?

No further follow-up is needed

Likely anorexia nervosa or bulimia

The client should immediately stop all medications

The client has normal eating patterns

The client only has mildly concerning eating patterns but does not need further evaluation

Question Title

* 4. Before making nutrition recommendations, which question best reflects a culturally responsive counseling approach? (Select all that apply)

“Will this recommendation help my patient lose weight?”

“Can the patient afford and access these foods?"

“Is the patient willing to stop eating foods labeled as ‘junk’?”

“Can the patient replace their habitual foods with healthier foods?”

“Who prepares meals in the household?”

“What meaning do these foods have for the patient or their family?”

Question Title

* 5. When should a dietitian communicate with the prescribing clinician? (Select all that apply)

Eating patterns become significantly restricted beyond what medication explains

Persistent GI side effects are affecting nutritional status

You observe behaviors suggesting disordered eating re-emergence

Client is using a compounded product

Question Title

* 6. Compounded GLP-1 products are FDA-approved versions of brand-name GLP-1 medications. (True or False)

True

False

Question Title

* 7. According to Dr. Beren's presentation, which of the following would be categorized as an eating disorder exclusively (Select all that apply)

Clinically diagnosable

Medical complications (e.g., electrolyte imbalance, malnutrition)

Requires specialist-level treatment

Eating past fullness regularly without distress

Yo-yo dieting

Question Title

* 8. Select the true statement

Disordered eating and eating disorders are the same thing clinically

Disordered eating is not a diagnosis, but it can still be clinically significant

Disordered eating only matters if the patient is underweight.

Eating disorders do not require specialist-level treatment unless weight loss is present

Question Title

* 9. A client answers “yes” to eating in secret and says their weight affects how they feel about themselves. Based on the ESP tool, what is the most appropriate next step?

No action; these are common concerns for a GLP-1 patient

Refer to a specialist for further evaluation

Monitor the GLP-1 dosage but make no changes

Focus specifically on protein and fiber goals for the GLP-1 appetite

Question Title

* 10. Which interpersonal screening questions are identified as often missed in GLP-1 care? (Select all that apply)

History of disordered eating

Restriction/binge cycles

Body image distress

Mental health changes

Question Title

* 11. A patient stopping GLP-1 treatment reports return of hunger, weight regain, panic, and shame. Which RD response aligns with patient care best practices?

Reinforce that weight regain indicates noncompliance

Normalize physiological responses, rebuild trust around eating, and address unresolved food rules

Recommend reducing caloric intake to offset sudden weight gain

Recommend re-starting GLP-1 medications

Question Title

* 12. What patient signals may be shared across both patients with disordered eating and eating disorders? (Select all that apply)

Preoccupation with food or weight

Emotional relationship with food

Weight stigma as a driver

DSM-5 diagnosis

Question Title

* 13. Part of the dietitian's role in GLP-1 care is: (Select all that apply)

Screen patients more deeply

Observe subtle concerns around food and eating

Escalate concerns to specialists, as needed

Advocate for supportive care across the interdisciplinary care team

Independently adjust medication dosage to best suit the patient

Thank you for completing the learner assessment. Please see below for instructions to access your CPE Certificate.

CPE Certificates
You can access CPE certificates for all Dietitian Connection webinars by logging into your account and clicking on the ‘CPEU/CPD Certificates’ heading located in the top right corner of the teal banner.

For a step-by-step guide, feel free to watch this video.

US Dietitians: CDR credentialed practitioners may share information regarding the quality of this CPE activity or any CDR prior approved activity with CDR staff by submitting the CDR CPEU Prior Approval Activity Complaint form on CDR’s website.

Learner Assessment: Enduring Activity"Are GLP-1s a double-edged syringe? Disordered eating guidance for dietitians in any setting"

Question Title

* 1. Please enter your name

Question Title

* 2. Please enter your email address

Question Title

* 3. What does a SCOFF score of 2 or more suggests?

Question Title

* 4. Before making nutrition recommendations, which question best reflects a culturally responsive counseling approach? (Select all that apply)

Question Title

* 5. When should a dietitian communicate with the prescribing clinician? (Select all that apply)

Question Title

* 6. Compounded GLP-1 products are FDA-approved versions of brand-name GLP-1 medications. (True or False)

Question Title

* 7. According to Dr. Beren's presentation, which of the following would be categorized as an eating disorder exclusively (Select all that apply)

Question Title

* 8. Select the true statement

Question Title

* 9. A client answers “yes” to eating in secret and says their weight affects how they feel about themselves. Based on the ESP tool, what is the most appropriate next step?

Question Title

* 10. Which interpersonal screening questions are identified as often missed in GLP-1 care? (Select all that apply)

Question Title

* 11. A patient stopping GLP-1 treatment reports return of hunger, weight regain, panic, and shame. Which RD response aligns with patient care best practices?

Question Title

* 12. What patient signals may be shared across both patients with disordered eating and eating disorders? (Select all that apply)

Question Title

* 13. Part of the dietitian's role in GLP-1 care is: (Select all that apply)

Learner Assessment: Enduring Activity
"Are GLP-1s a double-edged syringe? Disordered eating guidance for dietitians in any setting"